{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:49:45Z","timestamp":1792183785886,"version":"4.4.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"DOI":"10.1007\/s00592-024-02393-z","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T07:02:45Z","timestamp":1731654165000},"page":"743-752","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Autologous cell therapy for ischemic diabetic foot: a meta-analysis of randomized controlled trials for the development of the Italian guidelines for the treatment of diabetic foot syndrome"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3989-6484","authenticated-orcid":false,"given":"Alessia","family":"Scatena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Apicella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Mantuano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Ragghianti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Silverii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Monge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Uccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germano","family":"Scevola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Stabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Gargiulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Vermigli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Monami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Panel of the Italian Guidelines for the Treatment of Diabetic Foot Syndrome and on behalf of SID and AMD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Bernetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Cappella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"De Cassai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Lorenzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Medea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Stefanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Tramonta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Uccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"issue":"1","key":"2393_CR1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/s13287-022-03110-9","volume":"13","author":"Y Sun","year":"2022","unstructured":"Sun Y, Zhao J, Zhang L, Li Z, Lei S (2022) Effectiveness and safety of stem cell therapy for diabetic foot: a meta-analysis update. Stem Cell Res Ther 13(1):416. https:\/\/doi.org\/10.1186\/s13287-022-03110-9.","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"2393_CR2","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1111\/j.1464-5491.2005.01612.x","volume":"22","author":"E Faglia","year":"2005","unstructured":"Faglia E, Caravaggi C, Marchetti R et al. (2005) Screening for peripheral arterial disease by means of the ankle-brachial index in newly diagnosed type 2 diabetic patients. Diabet Med 22(10):1310\u20134. https:\/\/doi.org\/10.1111\/j.1464-5491.2005.01612.x.","journal-title":"Diabet Med"},{"issue":"5","key":"2393_CR3","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00125-008-0940-0","volume":"51","author":"L Prompers","year":"2008","unstructured":"Prompers L, Schaper N, Apelqvist J et al. (2008) Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease\u00a0The EURODIALE Study. \u00a0Diabetologia 51(5):747\u201355. https:\/\/doi.org\/10.1007\/s00125-008-0940-0.","journal-title":"\u00a0Diabetologia"},{"issue":"3","key":"2393_CR4","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.jvs.2014.03.290","volume":"60","author":"MR Nehler","year":"2014","unstructured":"Nehler MR, Duval S, Diao L et al. (2014) Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population. J Vasc Surg 60(3):686\u201395.e2. https:\/\/doi.org\/10.1016\/j.jvs.2014.03.290.","journal-title":"J Vasc Surg"},{"issue":"16","key":"2393_CR5","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.jacc.2016.02.040","volume":"67","author":"S Agarwal","year":"2016","unstructured":"Agarwal S, Sud K, Shishehbor MH (2016) Nationwide trends of hospital admission and outcomes among critical limb Ischemia patients: from 2003\u20132011. J Am Coll Cardiol 67(16):1901\u201313. https:\/\/doi.org\/10.1016\/j.jacc.2016.02.040.","journal-title":"J Am Coll Cardiol"},{"key":"2393_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.115.002938","author":"M Teraa","year":"2016","unstructured":"Teraa M, Conte MS, Moll FL, Verhaar MC (2016) Critical limb Ischemia: current trends and future directions. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/jaha.115.002938.","journal-title":"J Am Heart Assoc"},{"key":"2393_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9113745","author":"M Meloni","year":"2020","unstructured":"Meloni M, Izzo V, Da Ros V et al. (2020) Characteristics and outcome for persons with diabetic foot ulcer and no-option critical limb Ischemia. J Clin Med. https:\/\/doi.org\/10.3390\/jcm9113745.","journal-title":"J Clin Med"},{"issue":"4","key":"2393_CR8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2174\/1573399816999201001203111","volume":"17","author":"M Marco","year":"2021","unstructured":"Marco M, Valentina I, Daniele M et al. (2021) Peripheral arterial disease in persons with diabetic foot ulceration: a current comprehensive overview. Curr Diabetes Rev 17(4):474\u2013485. https:\/\/doi.org\/10.2174\/1573399816999201001203111","journal-title":"Curr Diabetes Rev"},{"key":"2393_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2019.05.006","author":"MS Conte","year":"2019","unstructured":"Conte MS, Bradbury AW, Kolh P et al. (2019) Global vascular guidelines on the management of chronic limb-threatening Ischemia. Eur J Vasc Endovasc Surg. https:\/\/doi.org\/10.1016\/j.ejvs.2019.05.006.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"8","key":"2393_CR10","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1161\/circresaha.116.309045","volume":"120","author":"M Rigato","year":"2017","unstructured":"Rigato M, Monami M, Fadini GP (2017) Autologous cell therapy for peripheral arterial disease: systematic review and meta-analysis of randomized, nonrandomized, and noncontrolled studies. Circ Res 120(8):1326\u20131340. https:\/\/doi.org\/10.1161\/circresaha.116.309045.","journal-title":"Circ Res"},{"key":"2393_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.diabres.2017.02.028","volume":"126","author":"M Dubsk\u00fd","year":"2017","unstructured":"Dubsk\u00fd M, Jirkovsk\u00e1 A, Bem R, Nemcov\u00e1 A, Fejfarov\u00e1 V, Jude EB (2017) Cell therapy of critical limb ischemia in diabetic patients - State of art. Diabetes research and clinical practice 126:263\u2013271. https:\/\/doi.org\/10.1016\/j.diabres.2017.02.028.","journal-title":"Diabetes research and clinical practice"},{"key":"2393_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11030889","author":"L Rehak","year":"2022","unstructured":"Rehak L, Giurato L, Meloni M, Panunzi A, Manti GM, Uccioli L (2022) The Immune-centric revolution in the diabetic foot: monocytes and lymphocytes role in wound healing and tissue regeneration-a narrative review. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11030889.","journal-title":"J Clin Med"},{"issue":"4","key":"2393_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells the international society for cellular therapy position statement. Cytotherapy 8(4):315\u20137. https:\/\/doi.org\/10.1080\/14653240600855905","journal-title":"Cytotherapy"},{"issue":"2","key":"2393_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/107632701300062859","volume":"7","author":"PA Zuk","year":"2001","unstructured":"Zuk PA, Zhu M, Mizuno H et al. (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7(2):211\u201328. https:\/\/doi.org\/10.1089\/107632701300062859","journal-title":"Tissue Eng"},{"issue":"5","key":"2393_CR15","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1177\/0003319715595172","volume":"67","author":"A Liew","year":"2016","unstructured":"Liew A, Bhattacharya V, Shaw J, Stansby G (2016) Cell therapy for critical limb Ischemia: a meta-analysis of randomized controlled trials. Angiology 67(5):444\u201355. https:\/\/doi.org\/10.1177\/0003319715595172.","journal-title":"Angiology"},{"key":"2393_CR16","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2021.5006","author":"A Magenta","year":"2021","unstructured":"Magenta A, Florio MC, Ruggeri M, Furgiuele S (2021) Autologous cell therapy in diabetes-associated critical limb ischemia: from basic studies to clinical outcomes. Int J Mol Med. https:\/\/doi.org\/10.3892\/ijmm.2021.5006.","journal-title":"Int J Mol Med"},{"issue":"2","key":"2393_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1253\/circj.71.196","volume":"71","author":"M Kajiguchi","year":"2007","unstructured":"Kajiguchi M, Kondo T, Izawa H, Kobayashi M et al. (2007) Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia. Circ J 71(2):196\u2013201. https:\/\/doi.org\/10.1253\/circj.71.196.","journal-title":"Circ J"},{"issue":"3","key":"2393_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1161\/01.res.85.3.221","volume":"85","author":"T Asahara","year":"1999","unstructured":"Asahara T, Masuda H, Takahashi T et al. (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85(3):221\u20138. https:\/\/doi.org\/10.1161\/01.res.85.3.221.","journal-title":"Circ Res"},{"issue":"11","key":"2393_CR19","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.3727\/096368912x657855","volume":"22","author":"F Bianchi","year":"2013","unstructured":"Bianchi F, Maioli M, Leonardi E et al. (2013) A new nonenzymatic method and device to obtain a fat tissue derivative highly enriched in pericyte-like elements by mild mechanical forces from human lipoaspirates. Cell Transplant 22(11):2063\u201377. https:\/\/doi.org\/10.3727\/096368912x657855.","journal-title":"Cell Transplant"},{"issue":"3","key":"2393_CR20","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3727\/096368912x636777","volume":"22","author":"E Benoit","year":"2013","unstructured":"Benoit E, O\u2019Donnell TF, Patel AN (2013) Safety and efficacy of autologous cell therapy in critical limb ischemia: a systematic review. Cell Transplant 22(3):545\u201362. https:\/\/doi.org\/10.3727\/096368912x636777.","journal-title":"Cell Transplant"},{"key":"2393_CR21","doi-asserted-by":"crossref","unstructured":"Ai M, Yan CF, Xia FC, Zhou SL, He J, Li CP (2016) Safety and efficacy of cell-based therapy on critical limb Ischemia: a meta-analysis. Cytotherapy 18(6):712\u201324.","DOI":"10.1016\/j.jcyt.2016.02.009"},{"issue":"11","key":"2393_CR22","doi-asserted-by":"publisher","first-page":"e2716","DOI":"10.1097\/md.0000000000002716","volume":"95","author":"X Jiang","year":"2016","unstructured":"Jiang X, Zhang H, Teng M (2016) Effectiveness of autologous stem cell therapy for the treatment of lower extremity ulcers: a systematic review and meta-analysis. Medicine\u00a0 95(11): e2716 https:\/\/doi.org\/10.1097\/md.0000000000002716","journal-title":"Medicine"},{"issue":"6","key":"2393_CR23","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.ejvs.2015.08.018","volume":"50","author":"SM Peeters Weem","year":"2015","unstructured":"Peeters Weem SM, Teraa M, de Borst GJ, Verhaar MC, Moll FL (2015) Bone marrow derived cell therapy in critical limb ischemia: a meta-analysis of randomized placebo controlled trials. Eur J Vasc Endovasc Surg 50(6):775\u201383. https:\/\/doi.org\/10.1016\/j.ejvs.2015.08.018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2393_CR24","doi-asserted-by":"publisher","unstructured":"Albiero M, Poncina N, Ciciliot S, Cappellari R, Menegazzo L, Ferraro F et al. 2015.\u00a0 Bone marrow macrophages contribute to diabetic stem cell mobilopathy by producing oncostatin M. Diabetes 64(8):2957\u201368. https:\/\/doi.org\/10.2337\/db14-1473","DOI":"10.2337\/db14-1473"},{"issue":"2","key":"2393_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.bbrc.2019.07.081","volume":"517","author":"O Inoue","year":"2019","unstructured":"Inoue O, Usui S, Takashima SI et al. (2019) Diabetes impairs the angiogenic capacity of human adipose-derived stem cells by reducing the CD271(+) subpopulation in adipose tissue. Biochem Biophys Res Commun 517(2):369\u2013375. https:\/\/doi.org\/10.1016\/j.bbrc.2019.07.081","journal-title":"Biochem Biophys Res Commun"},{"key":"2393_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.888809","author":"M Dubsk\u00fd","year":"2022","unstructured":"Dubsk\u00fd M, Hus\u00e1kov\u00e1 J, Bem R et al. (2022) Comparison of the impact of autologous cell therapy and conservative standard treatment on tissue oxygen supply and course of the diabetic foot in patients with chronic limb-threatening ischemia: a randomized controlled trial. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2022.888809","journal-title":"Front Endocrinol"},{"issue":"5","key":"2393_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1089\/ten.TEC.2014.0245","volume":"21","author":"B De Angelis","year":"2015","unstructured":"De Angelis B, Gentile P, Orlandi F et al. (2015) Limb rescue: a new autologous-peripheral blood mononuclear cells technology in critical limb ischemia and chronic ulcers. Tissue Eng Part C Methods 21(5):423\u201335. https:\/\/doi.org\/10.1089\/ten.TEC.2014.0245","journal-title":"Tissue Eng Part C Methods"},{"key":"2393_CR28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.avsg.2018.05.036","volume":"53","author":"F Persiani","year":"2018","unstructured":"Persiani F, Paolini A, Camilli D et al. (2018) Peripheral blood mononuclear cells therapy for treatment of lower limb ischemia in diabetic patients: a single-center experience. Ann Vasc Surg 53:190\u2013196. https:\/\/doi.org\/10.1016\/j.avsg.2018.05.036","journal-title":"Ann Vasc Surg"},{"key":"2393_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10102213","author":"A Scatena","year":"2021","unstructured":"Scatena A, Petruzzi P, Maioli F, Lucaroni F et al. (2021) Autologous peripheral blood mononuclear cells for limb salvage in diabetic foot patients with no-option critical limb Ischemia. J Clin Med. https:\/\/doi.org\/10.3390\/jcm10102213","journal-title":"J Clin Med"},{"issue":"1","key":"2393_CR30","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12933-022-01629-y","volume":"21","author":"A Panunzi","year":"2022","unstructured":"Panunzi A, Madotto F, Sangalli E et al. (2022) Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers. Cardiovasc Diabetol 21(1):196. https:\/\/doi.org\/10.1186\/s12933-022-01629-y","journal-title":"Cardiovasc Diabetol"},{"key":"2393_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12196123","author":"M Meloni","year":"2023","unstructured":"Meloni M, Giurato L, Andreadi A et al. (2023) Peripheral blood mononuclear cells: a new frontier in the management of patients with diabetes and no-option critical limb Ischaemia. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12196123","journal-title":"J Clin Med"},{"key":"2393_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12124148","author":"B Ragghianti","year":"2023","unstructured":"Ragghianti B, Berardi BM, Mannucci E, Monami M (2023) Autologous peripheral blood mononuclear cells in patients with small artery disease and diabetic foot ulcers: efficacy, safety, and economic evaluation. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12124148","journal-title":"J Clin Med"},{"issue":"11","key":"2393_CR33","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s00592-023-02150-8","volume":"60","author":"M Monami","year":"2023","unstructured":"Monami M, Scatena A, Miranda C et al. (2023) Development of the Italian clinical practice guidelines for the treatment of diabetic foot syndrome: design and methodological aspects. Acta Diabetol 60(11):1449\u20131469. https:\/\/doi.org\/10.1007\/s00592-023-02150-8","journal-title":"Acta Diabetol"},{"key":"2393_CR34","doi-asserted-by":"crossref","unstructured":"34. Moher D, Liberati A, Tetzlaff J, Altman DGJAoim. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. 2009","DOI":"10.1371\/journal.pmed.1000097"},{"key":"2393_CR35","doi-asserted-by":"crossref","unstructured":"35. Monami M, Scatena A, Miranda C., Monge L, De Cassai A, Volpe A, et al. Development of the Italian clinical practice guidelines for the treatment of diabetic foot syndrome: design and methodological aspects. Acta Diabetol 2023","DOI":"10.1007\/s00592-023-02150-8"},{"key":"2393_CR36","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC et al. (2011) The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. Bmj 343:d5928 https:\/\/doi.org\/10.1136\/bmj.d5928","journal-title":"Bmj"},{"issue":"2","key":"2393_CR37","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","volume":"66","author":"GH Guyatt","year":"2013","unstructured":"Guyatt GH, Oxman AD, Santesso N et al. (2013) GRADE guidelines: 12 preparing summary of findings tables-binary outcomes. J Clin Epidemiol 66(2):158\u201372. https:\/\/doi.org\/10.1016\/j.jclinepi.2012.01.012","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"2393_CR38","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.2337\/diacare.28.9.2155","volume":"28","author":"P Huang","year":"2005","unstructured":"Huang P, Li S, Han M, Xiao Z, Yang R, Han ZC (2005) Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care 28(9):2155\u201360. https:\/\/doi.org\/10.2337\/diacare.28.9.2155","journal-title":"Diabetes Care"},{"issue":"5","key":"2393_CR39","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1177\/0963689719835177","volume":"28","author":"D Lu","year":"2019","unstructured":"Lu D, Jiang Y, Deng W, Zhang Y, Liang Z, Wu Q et al. (2019) Long-term outcomes of BMMSC compared with BMMNC for Treatment of critical limb ischemia and foot ulcer in patients with diabetes. Cell Transplant 28(5):645\u2013652. https:\/\/doi.org\/10.1177\/0963689719835177","journal-title":"Cell Transplant"},{"issue":"1","key":"2393_CR40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1055\/s-0032-1311646","volume":"121","author":"L Mohammadzadeh","year":"2013","unstructured":"Mohammadzadeh L, Samedanifard SH, Keshavarzi A et al. (2013) Therapeutic outcomes of transplanting autologous granulocyte colony-stimulating factor-mobilised peripheral mononuclear cells in diabetic patients with critical limb ischaemia. Exp Clin Endocrinol Diabetes 121(1):48\u201353. https:\/\/doi.org\/10.1055\/s-0032-1311646","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"2393_CR41","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jdiacomp.2011.11.007","volume":"26","author":"A Ozturk","year":"2012","unstructured":"Ozturk A, Kucukardali Y, Tangi F et al. (2012) Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia. J Diabetes Compl 26(1):29\u201333. https:\/\/doi.org\/10.1016\/j.jdiacomp.2011.11.007","journal-title":"J Diabetes Compl"},{"issue":"11","key":"2393_CR42","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.3727\/096368910x514170","volume":"19","author":"V Proch\u00e1zka","year":"2010","unstructured":"Proch\u00e1zka V, Gumulec J, Jal\u016fvka F et al. (2010) Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer. Cell Transplant 19(11):1413\u201324. https:\/\/doi.org\/10.3727\/096368910x514170","journal-title":"Cell Transplant"},{"issue":"2","key":"2393_CR43","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S1000-1948(08)60031-3","volume":"23","author":"L Debin","year":"2008","unstructured":"Debin L, Youzhao J, Ziwen L, Xiaoyan L, Zhonghui Z, Bing C (2008) Autologous transplantation of bone marrow mesenchymal stem cells on diabetic patients with lower limb ischemia\u22c6 \u22c6Supported by the Clinical Research Fund of Southwest Hospital at Third Military Medical University (SWH2005A109). J Medl Colleges of PLA 23(2):106\u2013115. https:\/\/doi.org\/10.1016\/S1000-1948(08)60031-3","journal-title":"J Medl Colleges of PLA"},{"issue":"1","key":"2393_CR44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.diabres.2010.12.010","volume":"92","author":"D Lu","year":"2011","unstructured":"Lu D, Chen B, Liang Z, Deng W et al. (2011) Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Diabetes Res Clin Pract 92(1):26\u201336. https:\/\/doi.org\/10.1016\/j.diabres.2010.12.010","journal-title":"Diabetes Res Clin Pract"},{"key":"2393_CR45","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1479-5876-11-143","volume":"11","author":"PK Gupta","year":"2013","unstructured":"Gupta PK, Chullikana A, Parakh R et al. (2013) A double blind randomized placebo controlled phase I\/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia. J Transl Med 11:143. https:\/\/doi.org\/10.1186\/1479-5876-11-143","journal-title":"J Transl Med"},{"key":"2393_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-023-02185-x","author":"A Scatena","year":"2023","unstructured":"Scatena A, Apicella M, Mantuano M et al. (2023) Bypass surgery versus endovascular revascularization for occlusive infrainguinal peripheral artery disease: a meta-analysis of randomized controlled trials for the development of the Italian Guidelines for the treatment of diabetic foot syndrome. Acta Diabetol. https:\/\/doi.org\/10.1007\/s00592-023-02185-x","journal-title":"Acta Diabetol"},{"issue":"1","key":"2393_CR47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ccl.2014.09.008","volume":"33","author":"S Elsayed","year":"2015","unstructured":"Elsayed S, Clavijo LC (2015) Critical limb ischemia. Cardiol Clin 33(1):37\u201347. https:\/\/doi.org\/10.1016\/j.ccl.2014.09.008","journal-title":"Cardiol Clin"},{"key":"2393_CR48","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-024-02260-x","author":"M Monami","year":"2024","unstructured":"Monami M, Silverii A, Miranda C et al. (2024) Prostanoids in patients with diabetes and chronic limb-threatening ischemia: a meta-analysis of randomized clinical trials for the development of the Italian guidelines for the treatment of diabetic foot syndrome. Acta Diabetol. https:\/\/doi.org\/10.1007\/s00592-024-02260-x","journal-title":"Acta Diabetol"},{"key":"2393_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123307","author":"KJ Chiang","year":"2021","unstructured":"Chiang KJ, Chiu LC, Kang YN, Chen C (2021) Autologous Stem cell therapy for chronic lower extremity wounds: a meta-analysis of randomized controlled trials. Cells. https:\/\/doi.org\/10.3390\/cells10123307","journal-title":"Cells"},{"issue":"4","key":"2393_CR50","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.jvs.2021.10.051","volume":"75","author":"H Pu","year":"2022","unstructured":"Pu H, Huang Q, Zhang X et al. (2022) A meta-analysis of randomized controlled trials on therapeutic efficacy and safety of autologous cell therapy for atherosclerosis obliterans. J Vasc Surg 75(4):1440-1449.e5. https:\/\/doi.org\/10.1016\/j.jvs.2021.10.051","journal-title":"J Vasc Surg"},{"issue":"1","key":"2393_CR51","doi-asserted-by":"publisher","first-page":"21","DOI":"10.15283\/ijsc20088","volume":"4","author":"E Yunir","year":"2021","unstructured":"Yunir E, Kurniawan F, Rezaprasga E (2021) Autologous bone-marrow vs peripheral blood mononuclear cells therapy for peripheral artery disease in diabetic patients. Int J Stem Cells. 4(1):21\u201332. https:\/\/doi.org\/10.15283\/ijsc20088","journal-title":"Int J Stem Cells."},{"key":"2393_CR52","doi-asserted-by":"crossref","unstructured":"Fitridge R, Chuter V, Mills J, Hinchliffe R, Azuma N, Behrendt CA et al (2024) (2024) The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes and a foot ulcer. Diabetes Metab Res Rev. 40(3)","DOI":"10.1002\/dmrr.3686"},{"issue":"5","key":"2393_CR53","doi-asserted-by":"publisher","first-page":"382","DOI":"10.23736\/s0392-9590.22.04933-1","volume":"41","author":"N Troisi","year":"2022","unstructured":"Troisi N, D\u2019Oria M, Fernandes EFJ et al. (2022) International union of angiology position statement on no-option chronic limb threatening ischemia. Int Angiol 41(5):382\u2013404. https:\/\/doi.org\/10.23736\/s0392-9590.22.04933-1","journal-title":"Int Angiol"}],"updated-by":[{"DOI":"10.1007\/s00592-025-02455-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000}}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-024-02393-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-024-02393-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-024-02393-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T20:02:45Z","timestamp":1748376165000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-024-02393-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":53,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["2393"],"URL":"https:\/\/doi.org\/10.1007\/s00592-024-02393-z","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00592-025-02455-w","asserted-by":"object"}]},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]},"assertion":[{"value":"14 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"\"The original online version of this article was revised: due to the missing author's name 'Matteo Monami' in the article\".","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00592-025-02455-w","URL":"https:\/\/doi.org\/10.1007\/s00592-025-02455-w","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MM received speaking fees from Zuccato S.r.l. and Athena. The other authors do not have any direct relevant conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No statement is required since the present paper is a meta-analysis of previously published studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Standard Statements"}}]}}